TickerFacts.

Medline Inc. (MDLN): R&D Expense

Annual figures by period end, from SEC filings.

$80.00M
Year ended 2025-12-31
2023-12-31: $60.00M2024-12-31: $67.00M2025-12-31: $80.00M$80.00M
2023-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$80.00M+19.4%2026-02-25, From 2025-01-01
2024-12-31$67.00M+11.7%2026-02-25, From 2024-01-01
2023-12-31$60.00Mn/a2026-02-25, From 2023-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Medline Inc. (MDLN)2025-12-31$80.00M+19.4%
Stryker Corp (SYK)2025-12-31$1.62B+10.7%
3M Co (MMM)2024-12-31$700.00M0.0%
Becton Dickinson & Co (BDX)2025-09-30$1.26B+6.3%
Boston Scientific Corp (BSX)2025-12-31$2.05B+27.1%
Baxter International Inc (BAX)2025-12-31$518.00M-12.2%
Solventum Corp (SOLV)2025-12-31$739.00M-4.6%
ResMed Inc (RMD)2026-06-30$378.29M+14.2%
Dexcom Inc (DXCM)2025-12-31$599.10M+8.5%

Compare MDLN, SYK, MMM, BDX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗